Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
60.27
Open
60.18
Day Range59.73 – 61.77
59.73
61.77
52W Range14.79 – 61.77
14.79
61.77
97% of range
50-Day MA
47.63(+26.9%)
200-Day MA
31.11(+94.3%)
VOLUME & SIZE
Avg Volume
1.4M
FUNDAMENTALS
P/E Ratio
-36.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
71
Overbought
ELVN News
About
enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.